Tests currently used to determine whether an unborn child has Down syndrome carry a small risk of miscarriage, but a new test for the genetic abnormality could solve that problem by getting results from a maternal blood sample. The test, expected on the market this year, analyzes fetal RNA and DNA in the maternal blood serum for specific genetic markers found on chromosome 21. The number of copies of each of these markers reveals whether the fetal DNA has an extra copy of the chromosome–the genetic variation that causes Down syndrome.
Product: SEQureDx
Cost: Not available
Don’t settle for half the story.
Get paywall-free access to technology news for the here and now.
MIT Technology Review provides an intelligent and independent filter for the flood of information about technology.
Subscribe now Already a subscriber? Sign in
Your daily newsletter about what’s up in emerging technology from MIT Technology Review.
Our most popular stories
-
Large language models can do jaw-dropping things. But nobody knows exactly why.
Will Douglas Heaven -
How scientists traced a mysterious covid case back to six toilets
Cassandra Willyard -
It’s time to retire the term “user”
Taylor Majewski -
The problem with plug-in hybrids? Their drivers.
Casey Crownhart